Medical Emergencies News
-
Showcase
Aktiv Pharma Group Receives Grant Funding to Develop Tranexamic Acid Autoinjector
Broomfield Colorado 6/25/2022. Aktiv Pharma Group (Aktiv) announced today a grant award from the U.S. Department of Defense (DOD) Defense Health Agency (DHA) Joint Program Committee 6/Combat Casualty Care Research Program (JPC-6/CCCRP) [1] for the continued development of a tranexamic acid (TXA) autoinjector, targeting proposed indications related to prehospital treatment of severe bleeding. ...
-
Showcase
Neurescue`s Breakthrough Intelligent Balloon Catheter FDA 510(k) Cleared for Hemorrhage Control and IDE Approved for Cardiac Arrest
COPENHAGEN, Denmark--(BUSINESS WIRE)--Neurescue, a medical device company developing innovative cardiovascular solutions to improve the outcomes for emergency patients, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market the company’s NEURESCUE® device for temporary occlusion of large vessels, including patients requiring emergency ...
By Neurescue
-
Showcase
Zeneo® Adrenaline: A New Innovative Formulation
Anaphylactic shock is an absolute medical emergency. When anaphylactic shock is suspected, emergency services must be called and emergency first aid administered immediately. The only first-line treatment for anaphylactic shock is injectable adrenaline1. In the USA: 1.6% to 5.1% of the population has experienced anaphylactic shock, 1% of hospitalizations are caused by it, 0.1% of patients ...
By Crossject
-
Impel Pharmaceuticals Announces Filing of Voluntary Chapter 11 Cases and Signing of `Stalking Horse` Agreement to Facilitate Sale
Patient Access to Trudhesa® to Continue Uninterrupted Sufficient Liquidity to Fund Day to Day Operations During Court-Supervised Process Impel Pharmaceuticals Inc. (OTCQX: IMPL) ("Impel" or "the Company"), a commercial-stage biopharmaceutical company with a mission to develop transformative therapies for people suffering from diseases with high unmet medical needs, today announced that ...
-
Practicing in the Digital Age: The Benefits of the SurgiCam HD
Summary The SurgiCam® HD, a specialized point-of-view camera designed for clinicians, plays a pivotal role in the documentation, education, and analysis of surgical, dental, and veterinary procedures. Its high-quality image and video capturing capabilities make it an indispensable tool in these fields. This innovative camera significantly enhances surgical practices, education, and research ...
-
CD Genomics Revolutionizes Pathogen Discovery with the Launch of Viral Metagenomic Sequencing Service
CD Genomics, a global leader in genomic and bioinformatics solutions, is pleased to announce the official launch of its Viral Metagenomic Sequencing service. This state-of-the-art offering represents a major advancement in the field of pathogen research and promises to provide unparalleled insights into viral communities. Viruses, being the most abundant entities on our planet, play a pivotal ...
By CD Genomics
-
7-year-old Boy Managing His Hydrocephalus with ReFlow Ventricular System “Gen 1” Featured on Charleston’s ABC News 4
After struggling to conceive a child for what felt like ages, Miranda of Moncks County, South Carolina finally fell pregnant - a miracle that quickly turned into horror when she delivered at 24 weeks in late 2015. At just 1 pound and 12 ounces, her son, Sutton, arrived with life-threatening health issues, including hydrocephalus - a neurological disorder caused by an abnormal buildup of ...
-
Protea and Markonis celebrate the first 5 years of collaboration
This year Protea celebrates 5 years of collaboration with the Serbian company Markonis in the ambulance field for the Balkan area. Markonis is a renowned company based in Niš in Serbia specialized in the production and fitting of ambulances and special vehicles. With a long history of over 30 years, Markonis has established itself in the ambulance field as a reliable, experienced and ...
By ProTeA srl
-
BARDA-funded Intranasal Antibody Cocktail for COVID-19 Shows Promise in a Preclinical Study
Lumen Bioscience — a clinical stage biopharmaceutical company developing biologic drugs for highly prevalent diseases — announced today preliminary results from a Biomedical Advanced Research and Development Authority (BARDA)-supported effort to develop an intranasal formulation of its drug candidate, LMN-301. This drug, produced in spirulina, contains an antibody cocktail for ...
-
BRIM Biotech submits US Phase 3 clinical trial protocol for BRM421 in the treatment of dry eye disease to the FDA
BRIM Biotechnology, Inc. (“BRIM,” TPEx 6885) announced today that it has officially submitted the Phase 3 clinical trial protocol for BRM421 in the treatment of dry eye disease (DED) to the U.S. Food and Drug Administration (FDA). If the FDA has no further comments after the 30-day review period, BRIM will proceed to initiate the Phase 3 clinical trial in December. Based on its ...
-
CELLVIE presents at the Rejuvenation Startup Summit organized by Kizoo in Berlin
The Rejuvenation Startup Summit created by the Forever Healthy Foundation, is a vibrant networking event that aims to accelerate the development of the rejuvenation biotech industry. It is the world's largest gathering of Longevity startups in-person. The Summit brings together startups, members of the longevity venture capital/investor ecosystem, and researchers interested in founding or joining ...
By cellvie Inc.
-
Early detection of concussion can mitigate premature returning to play decisions
An interview with the lead author from The American Journal of Sports Medicine, Effects of the New York State Concussion Management and Awareness Act (“Lystedt Law”) on Concussion-Related Emergency Health Care Utilization Among Adolescents, 2005-2015 (here). More on Zack Lystadt's concussion survivor's journey (here). ...
-
COVID-19 Global Research Collaboration
Healthbit has partnered with LSE – London School of Economics and Political Science, to launch a global initiative which aims to assess the impact of the COVID-19 lockdown on the lives of people, including students and staff. Academic organisations from all over the world have joined this initiative with more getting in contact each day. This will help maximise the project’s ...
-
Enalare Therapeutics Receives Orphan Drug Designation From the U.S. FDA on ENA-001 for the Treatment of Apnea of Prematurity (AoP)
ENA-001, a New Chemical Entity (NCE) with a novel mechanism of action as an agnostic respiratory stimulant, has previously been granted Rare Pediatric Disease designation for the Treatment of AoP by the FDA, with eligibility for a priority review voucher (PRV). The compound is also being developed by Enalare for the treatment of post-operative respiratory depression and community drug overdose. ...
-
SIGA Announces Approximately $16 Million of International Procurement Orders Received in August and Early September for Oral TPOXX® (Tecovirimat)
NEW YORK, Sept. 26, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced receipt of approximately $16 million of international procurement orders for oral TPOXX® (tecovirimat) in August and early September, including an approximate $10 million order by the European Commission, ...
-
Meet us at PDA 2022
2022 PDA : the Scientific Program Planning Committee and the PDA have joined forces with the Lyophilization Conference to provide a comprehensive experience that includes all emerging trends in biomanufacturing. In this context, Indatech teams will be present at the 2022 PDA BioManufacturing Conference with great demonstrations of NIR Hyperspectral and UV VIS! The health emergency has ...
-
Robocath’s joint venture, Cathbot, concludes first clinical study in China to evaluate robotic PCI safety and efficacy
End of study brings Robocath closer to commercializing R-One in China in 2023 149 patients enrolled over six months in four Chinese centers Results of first vascular robotics study on this scale in China will be published in March 2023 Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, announces today that ...
By Robocath
-
Amerigo Scientific Launches Anex® Brush for Optimal Sampling
Amerigo Scientific, a distributor focused on providing critical products and services to the biomedical and life science communities, recently announced the release of a new Anex® Brush that allowed optimal sampling the entire anal canal including the anal transformation zone, without the need for a proctoscope or anoscope. Amerigo Scientific provides high-quality and cost-effective medical ...
-
IV Dislodgement Is a Common Problem in Vascular Access, Clinicians Say
Portsmouth, N.H. – IV dislodgement is a near-daily problem for clinicians and their patients, according to a recent focus group of vascular access experts. The clinicians also reported there is a need for better technology to mitigate the potentially serious consequences of frequent IV dislodgements. “This research discussion addressed a frustrating problem that those of us in ...
-
CD Formulation Provides Comprehensive Formulation Development and Analytical Services for the pharmaceutical Industry
Formulation development is of paramount importance for new drug development as it can determine patentability, lifecycle and, ultimately, the success of a pharmaceutical product. Fully aware of the challenges that may arise from this process, CD Formulation recently announces that it now provides a comprehensive range of formulation development and analytical services for the pharmaceutical ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you